These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6448492)

  • 1. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
    Lien JT
    Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction.
    Sahay JN; Chatterjee SS; Summerfield PJ
    Br J Clin Pract; 1986 May; 40(5):198-202. PubMed ID: 2944533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease].
    Malinowski R; Frank-Piskorska A; Wasek Z; Koczorowski T
    Pneumonol Pol; 1986 Mar; 54(3):91-5. PubMed ID: 2942842
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with Atrovent in coal miners.
    Minette A; Marcq M
    Scand J Respir Dis Suppl; 1979; 103():192-9. PubMed ID: 155298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 9. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
    Bezel R; Brändli O; Braun P; Haegi V; Helcl J; Villiger B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):632-6. PubMed ID: 2956661
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease.
    Petersen BN; Weeke E
    Scand J Respir Dis Suppl; 1979; 103():178-82. PubMed ID: 155295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of ipratropium (Atrovent) in the treatment of chronic obstructive lung diseases in myasthenic patients treated with anticholinesterase agents. Apropos of a case].
    Robinet G; Leroyer C; Andre J; Dewitte JD; Clavier J
    Rev Pneumol Clin; 1989; 45(4):161-3. PubMed ID: 2533994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The background to Duovent.
    Phillips VJ
    Postgrad Med J; 1984; 60 Suppl 1():13-7. PubMed ID: 6233545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ipratropine and terbutaline. A comparative study of 19 patients with chronic obstructive lung diseases].
    Petersen BN; Weeke E
    Ugeskr Laeger; 1979 Sep; 141(36):2439-42. PubMed ID: 160643
    [No Abstract]   [Full Text] [Related]  

  • 15. A placebo-controlled comparison between the bronchodilatory effects of ipratropium bromide inhaled as a dry powder and by metered dose inhaler in chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ
    Ann Allergy; 1988 Nov; 61(5):341-3. PubMed ID: 2973269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings].
    Koch G
    Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical use of atrovent].
    Zamotaev IP; Maksimova LN
    Klin Med (Mosk); 1984 Apr; 62(4):50-4. PubMed ID: 6234428
    [No Abstract]   [Full Text] [Related]  

  • 18. [Function studies of an atropine derivative--ipratropium bromide in an aerosol device--in patients with chronic obstructive bronchopneumopathies].
    Mairesse M; Ledent C
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):196-9. PubMed ID: 162192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipratropium.
    Med Lett Drugs Ther; 1987 Jul; 29(745):71-2. PubMed ID: 2885730
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung Health Study.
    Anthonisen NR
    Am Rev Respir Dis; 1989 Oct; 140(4):871-2. PubMed ID: 2529803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.